2019
DOI: 10.1021/acs.analchem.9b04639
|View full text |Cite
|
Sign up to set email alerts
|

Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

5
2

Authors

Journals

citations
Cited by 44 publications
(39 citation statements)
references
References 187 publications
0
35
0
Order By: Relevance
“…On the one hand, the approach of employing urinary reporting levels and decision limits has offered substantial practicality and harmonization at both laboratory and result managing authority (RMA) level; on the other hand, individualized case management cannot be guaranteed, 4 and differing drug potencies and, consequently, pharmacologically relevant blood concentrations and corresponding urinary levels are not fully accounted for. Information complementing the urine sample analytical data are desirable that support and particularize the decision‐making process by the RMA, ideally by either verifying or falsifying the presence of pharmacologically relevant blood levels of a prohibited substance in an athlete's sample collected in−/post‐competition 5 .…”
Section: Potential Alternative/complementary Strategymentioning
confidence: 99%
“…On the one hand, the approach of employing urinary reporting levels and decision limits has offered substantial practicality and harmonization at both laboratory and result managing authority (RMA) level; on the other hand, individualized case management cannot be guaranteed, 4 and differing drug potencies and, consequently, pharmacologically relevant blood concentrations and corresponding urinary levels are not fully accounted for. Information complementing the urine sample analytical data are desirable that support and particularize the decision‐making process by the RMA, ideally by either verifying or falsifying the presence of pharmacologically relevant blood levels of a prohibited substance in an athlete's sample collected in−/post‐competition 5 .…”
Section: Potential Alternative/complementary Strategymentioning
confidence: 99%
“…The accomplished analytical sensitivities in routine doping controls are of particular importance when considering the desirable retrospectivity of sample analyses. Detection limits as reported above can, however, also result in AAFs when contaminated products are consumed as reported in the past, especially in the case of diuretics such as hydrochlorothiazide . In that context, Favretto et al discussed a case of contaminated dietary supplements that were obtained from a compounding pharmacy and used by an athlete, whose doping control samples returned two AAFs for hydrochlorothiazide at concentrations below 10 ng/mL .…”
Section: Diuretics and Other Masking Agents Stimulants Narcotics Amentioning
confidence: 91%
“…ARE-luciferase reporter assay in HEK293 cells suggested that the active constituent of YK11 was 2a. Although YK11 is sold via the internet as an anabolic steroid, it is an experimental drug candidate and a non-approved substance for humans [10][11][12]. It should be noted that YK11 has not been studied in humans or even animals.…”
Section: Synthesis Of Yk11 (2a)mentioning
confidence: 99%